Chickenpox, caused by the varicella-zoster virus, can pose serious risks to pregnant women and their unborn babies. If a woman who is 36 weeks pregnant presents with chickenpox, it is important to treat her promptly to reduce the risk of complications.

Acyclovir is the recommended treatment for chickenpox in pregnant women. It is an antiviral medication that can help reduce the severity and duration of the illness. There is no documented evidence of harm to the fetus when acyclovir is used to treat chickenpox during pregnancy.

Painkillers alone are not sufficient to treat chickenpox in a pregnant woman, as they do not address the underlying viral infection. Immediate delivery of the child is not necessary unless there are other complications present. Varicella zoster immune globulin should be given to the infant after birth, not the mother. Steroids can actually make the chickenpox infection worse, so they should be avoided in this situation.

In conclusion, the correct treatment for a pregnant woman at 36 weeks gestation with chickenpox is acyclovir. It is important to consult with a healthcare provider for proper management and monitoring of the condition.

During pregnancy and breastfeeding, it is important for women living with HIV to continue taking antiretroviral therapy (ART) to prevent transmission of the virus to their baby. In addition to viral load monitoring, which measures the amount of HIV in the blood, CD4 count monitoring is also crucial. CD4 cells are a type of white blood cell that helps the immune system fight off infections. Monitoring CD4 counts can help healthcare providers assess the immune function of the mother and determine if the ART regimen is effectively controlling the virus.

Toxicity monitoring is also important for pregnant or breastfeeding women on ART. Some antiretroviral medications can have side effects that may be harmful to the mother or the developing baby. Regular monitoring for signs of toxicity, such as liver function tests, can help healthcare providers adjust the treatment regimen if necessary to minimize any potential risks.

In summary, pregnant or breastfeeding women on ART should undergo CD4 count and toxicity monitoring in addition to viral load monitoring to ensure the safety and effectiveness of their treatment.

Isoniazid (INH) is a medication commonly used for the prevention and treatment of tuberculosis (TB). When it comes to TB preventive therapy (TPT) in infants, the maximum daily dose of INH is typically 300 mg. This dosage is based on the weight and age of the infant, as well as the severity of the TB infection. It is important to follow the prescribed dosage and duration of treatment as recommended by a healthcare provider to ensure the effectiveness of the medication and to minimize the risk of side effects. Overdosing on INH can lead to serious health complications, so it is crucial to adhere to the prescribed dosage guidelines.

Diagnosis and Management of HIV Nephropathy

HIV infection is a high possibility in a patient with risk factors and presenting with emaciation, oral ulcers, and lymphopenia. A CD4 count and HIV serological testing should be done urgently. HIV nephropathy is a common complication, with focal and segmental glomerulosclerosis being the most common pathological diagnosis. Other variants include membranoproliferative nephropathy, diffuse proliferative glomerulonephritis, minimal change disease, and IgA nephropathy. Treatment involves ACE inhibitors and antiretroviral therapy, with dialysis being necessary in end-stage disease. Renal biopsy is required to confirm the diagnosis, but HIV testing should be performed first. Serum IgA levels are elevated in IgA nephropathy, while serum complement levels and anti-nuclear factor are needed in SLE-associated nephropathy or other connective tissue diseases or vasculitis. However, the lack of systemic symptoms points away from these diagnoses.

Chancroid is a sexually transmitted infection caused by the bacterium Haemophilus ducreyi. It typically presents as painful genital ulcers that can bleed and have a characteristic appearance. In this case, the 4cm bleeding ulcer on the woman’s labia minora is likely due to chancroid.

When a chancroid ulcer is present, it can drain to the lymph nodes in the groin region. The lymph nodes that are most commonly affected in this case are the superficial inguinal lymph nodes. These nodes are located in the groin area and are responsible for draining lymphatic fluid from the lower extremities, external genitalia, and perineum.

Therefore, in this scenario, the bleeding ulcer on the woman’s labia minora would likely drain to the superficial inguinal lymph nodes. It is important to consider the possibility of chancroid in sexually active individuals presenting with genital ulcers, as prompt diagnosis and treatment are essential to prevent complications and further spread of the infection.

Esophageal candidiasis is a fungal infection caused by Candida species, most commonly Candida albicans. Fluconazole is a preferred drug for the treatment of severe recurrent esophageal candidiasis due to its high efficacy and safety profile. It is a triazole antifungal medication that works by inhibiting the synthesis of ergosterol, a key component of the fungal cell membrane.

Nystatin is another antifungal medication that is commonly used for the treatment of oral candidiasis, but it is not as effective for esophageal candidiasis. Itraconazole is also effective for esophageal candidiasis, but fluconazole is generally preferred due to its better tolerability and ease of administration.

Amphotericin B is a polyene antifungal medication that is reserved for severe cases of esophageal candidiasis that are resistant to other antifungal drugs. Caspofungin is an echinocandin antifungal medication that is typically used for invasive fungal infections, but it may also be considered for the treatment of esophageal candidiasis in certain cases.

Anal cancer is primarily caused by HPV infection, which is the most significant risk factor. Other factors may also contribute, but the link between HPV infection and anal cancer is the strongest. This is similar to how HPV infection can lead to cervical cancer by causing oncogenic changes in the cervical mucosa.

Understanding Anal Cancer: Definition, Epidemiology, and Risk Factors

Anal cancer is a type of malignancy that occurs exclusively in the anal canal, which is bordered by the anorectal junction and the anal margin. The majority of anal cancers are squamous cell carcinomas, but other types include melanomas, lymphomas, and adenocarcinomas. The incidence of anal cancer is relatively rare, with an annual rate of about 1.5 in 100,000 in the UK. However, the incidence is increasing, particularly among men who have sex with men, due to widespread infection by human papillomavirus (HPV).

There are several risk factors associated with anal cancer, including HPV infection, anal intercourse, a high lifetime number of sexual partners, HIV infection, immunosuppressive medication, a history of cervical cancer or cervical intraepithelial neoplasia, and smoking. Patients typically present with symptoms such as perianal pain, perianal bleeding, a palpable lesion, and faecal incontinence.

To diagnose anal cancer, T stage assessment is conducted, which includes a digital rectal examination, anoscopic examination with biopsy, and palpation of the inguinal nodes. Imaging modalities such as CT, MRI, endo-anal ultrasound, and PET are also used. The T stage system for anal cancer is described by the American Joint Committee on Cancer and the International Union Against Cancer. It includes TX primary tumour cannot be assessed, T0 no evidence of primary tumour, Tis carcinoma in situ, T1 tumour 2 cm or less in greatest dimension, T2 tumour more than 2 cm but not more than 5 cm in greatest dimension, T3 tumour more than 5 cm in greatest dimension, and T4 tumour of any size that invades adjacent organ(s).

In conclusion, understanding anal cancer is crucial in identifying the risk factors and symptoms associated with this type of malignancy. Early diagnosis and treatment can significantly improve the prognosis and quality of life for patients.

HIV is a virus that is primarily transmitted through specific routes, including sexual contact, blood transfusion, sharing needles, and vertical transmission from mother to child. Casual contact, such as hugging, kissing, or sharing food or drinks, does not transmit HIV. This is because the virus is not spread through saliva, sweat, tears, or casual contact with an infected person. It is important to understand the transmission routes of HIV in order to prevent the spread of the virus and protect oneself and others from infection.

Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. If left untreated in pregnant women, syphilis can be transmitted to the fetus during pregnancy or childbirth, leading to congenital syphilis. Congenital syphilis can result in a range of serious complications for the newborn, including stillbirth, neonatal meningitis, and other severe health issues.

Placental abruption, premature rupture of membranes, and stillbirth can also occur as complications of untreated syphilis in pregnant women, but congenital syphilis is the most common complication. This is because the bacterium can easily cross the placenta and infect the fetus, leading to a higher likelihood of congenital syphilis compared to other complications. Therefore, it is crucial for pregnant women to receive timely screening and treatment for syphilis to prevent these serious complications for both themselves and their babies.

The two drugs that act by inhibiting viral reverse transcriptase are the NRTIs (nucleoside reverse transcriptase inhibitors) and NNRTIs (non-nucleoside reverse transcriptase inhibitors). NRTIs work by competing with the natural nucleotides that the virus needs to replicate its genetic material, while NNRTIs bind to a different site on the reverse transcriptase enzyme to prevent it from functioning properly.

In the recommended regimens for post-exposure prophylaxis, the options include using 3 NRTIs, 2 NRTIs plus 1 NNRTI, or using a PI (protease inhibitor) or INI (integrase inhibitor). These combinations of antiviral drugs are effective in preventing the replication of HIV and reducing the risk of acquiring the infection after exposure.

Hepatitis B infection during pregnancy can pose a risk to both the mother and the fetus. Screening for HBV is crucial in pregnant women, regardless of previous vaccination status, as it helps in identifying those who may require interventions to prevent transmission to the baby.

The risk of fetal infection is higher with chorionic villus sampling than amniocentesis because chorionic villus sampling involves obtaining a sample of the placental tissue, which may contain the virus.

Women with a high viral load in the third trimester should be offered antiviral therapy to reduce the risk of transmission to the baby. Caesarean section does not reduce the risk of hepatitis B transmission, as the virus is primarily transmitted through exposure to infected blood or body fluids during childbirth.

Fetal scalp blood sampling in labor should be avoided to prevent potential exposure to the virus. Therefore, all statements are true except for the statement that screening for HBV is not recommended for a pregnant woman with previous vaccination.

The individual has bipolar disorder and needs ongoing treatment. The recommended initial medications are Lithium and Valproate. However, due to the person’s eGFR of 45, which indicates stage 3a CKD, Lithium is not a viable option. It is important to note that an eGFR < 90 in a working age adult is a strong indication of renal impairment, although a detailed understanding of CKD is not necessary for the MRCPsych exams. Therefore, Valproate is the preferred treatment in this case. HIV and Mental Health: Understanding the Relationship and Treatment Options Human immunodeficiency virus (HIV) is a blood-borne virus that causes cellular immune deficiency, resulting in a decrease in the number of CD4+ T-cells. People with severe mental illness are at increased risk of contracting and transmitting HIV, and the prevalence of HIV infection among them is higher than in the general population. Antiretroviral drugs are used to manage HIV, but they are not curative. Depression is the most common mental disorder in the HIV population, and it can result from HIV of the psycho-social consequences of having the condition. HIV-associated neurocognitive disorder (HAND) is the umbrella term for the spectrum of neurocognitive impairment induced by HIV, ranging from mild impairment through to dementia. Poor episodic memory is the most frequently reported cognitive difficulty in HIV-positive individuals. Treatment options for mental health issues in people with HIV include atypical antipsychotics for psychosis, SSRIs for depression and anxiety, valproate for bipolar disorder, and antiretroviral therapy for HAND. It is important to avoid benzodiazepines for delirium and MAOIs for depression. Understanding the relationship between HIV and mental health and providing appropriate treatment options can improve the quality of life for people living with HIV.

Herpes zoster, also known as shingles, is caused by the reactivation of the varicella zoster virus, which initially causes chickenpox. When the virus reactivates, it can cause painful vesicular lesions in a specific dermatome area, such as the ear canal in this case. The high-grade fever may be present due to the infection.

Varicella zoster is the virus responsible for chickenpox, not shingles. Measles is caused by the measles virus and presents with a characteristic rash, but not tender lesions in a specific area. Herpes simplex virus can cause cold sores or genital herpes, but not the specific presentation described in the question. HIV is a virus that attacks the immune system and can lead to various opportunistic infections, but it does not typically present with tender lesions in a specific area like herpes zoster.

The most likely organism responsible for the presentation of weight loss, night sweats, and abdominal pain in a 45-year-old female with a tubo-ovarian mass is Mycobacterium tuberculosis. This is because the constitutional symptoms of weight loss, evening pyrexia, and night sweats are classic signs of tuberculosis. TB can affect any part of the body, including the reproductive organs, leading to the formation of masses such as the tubo-ovarian mass seen on the ultrasound scan.

Chlamydia trachomatis, Neisseria gonorrhoeae, and Staphylococcus aureus are not typically associated with the symptoms described in this case. Entamoeba histolytica is a parasitic infection that can cause abdominal pain, but it is not commonly associated with weight loss and night sweats.

Therefore, given the clinical presentation and the presence of a tubo-ovarian mass, Mycobacterium tuberculosis is the most likely organism responsible for this patient’s symptoms. Further testing, such as a biopsy or culture of the mass, may be needed to confirm the diagnosis.

Cytomegalovirus (CMV) is a common virus that can infect people of all ages. The incubation period refers to the time between when a person is exposed to the virus and when they start showing symptoms of the infection.

The incubation period for CMV is typically 3-12 weeks. This means that after being exposed to the virus, it can take anywhere from 3 to 12 weeks for symptoms to appear. During this time, the virus may be replicating in the body without causing any noticeable symptoms.

It is important to note that some people infected with CMV may never develop symptoms, while others may experience mild flu-like symptoms or more severe complications. If you suspect you have been exposed to CMV or are experiencing symptoms, it is important to consult with a healthcare provider for proper diagnosis and treatment.

Hepatitis C virus (HCV) can be transmitted from mother to baby during pregnancy and childbirth, although the risk is relatively low compared to other bloodborne viruses like HIV. Fetal scalp blood sampling is an invasive procedure that can increase the risk of vertical transmission of HCV, especially if the mother has a high viral load at the time of delivery. Therefore, it is recommended to avoid this procedure in pregnant women with HCV.

Caesarean section has not been shown to significantly reduce the risk of HCV transmission from mother to baby, so it is not considered a preventive measure in this case. However, the baby should be screened for hepatitis C shortly after delivery to determine if transmission has occurred.

The co-existence of HIV can increase the risk of HCV transmission, so it is important for the pregnant woman to be tested for HIV as well. Breastfeeding is generally considered safe for women with HCV, as long as there are no cracks or bleeding in the nipples that could potentially expose the baby to infected blood.

In conclusion, fetal scalp blood sampling should be avoided in pregnant women with HCV to reduce the risk of vertical transmission to the baby. Other measures such as screening the baby after delivery and testing for HIV should also be taken to ensure the health of both the mother and the baby.

The true statement regarding herpes simplex virus type I is that more than half of the population is infected. This is because HSV-1 is very common and is often acquired orally during childhood through activities such as sharing utensils or kissing. It can also be sexually transmitted, including through oral sex. HSV-1 tends to remain latent in the trigeminal ganglia, which are located in the head and neck region. Reactivation of the virus can occur due to various triggers such as illnesses, stress, fatigue, or exposure to sunlight. It is important to note that shingles is actually caused by the reactivation of the varicella zoster virus, not HSV-1.

Penicillin uses the mechanism of action to inhibit cell wall synthesis in bacteria. Bacteria constantly remodel their peptidoglycan cell walls as they grow and divide. Penicillin works by binding to the enzyme DD-transpeptidase, which is responsible for forming peptidoglycan cross-links in the cell wall. By binding to this enzyme, penicillin prevents the formation of these cross-links, leading to an imbalance between cell wall production and degradation. This imbalance ultimately causes the bacterial cell to die. This mechanism of action makes penicillin an effective antibiotic for treating bacterial infections.

During pregnancy, it is important to consider the risks and benefits of any medication or treatment, including TB preventive therapy (TPT). A positive TB symptom screen, alcohol abuse, liver disease, known hypersensitivity to INH, and prior history of TB exposure are all considered contraindications to TPT during pregnancy due to potential risks to the mother and fetus.

A positive TB symptom screen indicates active TB infection, which requires treatment with different medications than TPT. Alcohol abuse can affect the metabolism and effectiveness of TB medications. Liver disease can impact the ability to metabolize medications properly. Known hypersensitivity to INH can lead to severe allergic reactions.

However, a prior history of TB exposure is not considered a contraindication to TPT during pregnancy. In fact, if a pregnant woman has been exposed to TB in the past, she may be at higher risk of developing active TB during pregnancy and could benefit from TPT to prevent this outcome.

The question is asking which complement component is most likely deficient in the 18-year-old male who has had two episodes of meningococcal meningitis.

The complement system is a part of the immune system that helps to clear pathogens from the body. In the case of meningitis, the complement system plays a crucial role in the inflammatory response in the subarachnoid space.

Among the options provided, C5 is the most likely complement component to be deficient in this patient. This is because C5 fragment levels in the cerebrospinal fluid of patients with bacterial meningitis have been shown to correlate with poor prognosis. Therefore, a deficiency in C5 could potentially lead to recurrent episodes of meningitis in this patient.

In summary, the most probable deficiency in the 18-year-old male with recurrent meningococcal meningitis is C5.

Varicella zoster, also known as chickenpox, is a highly contagious viral infection that can cause serious complications in certain populations, such as pregnant women who are not immune to the virus. In this case, pregnant women who test negative for antibodies should be administered immunoglobulin within 4 days of exposure to the virus to prevent the development of varicella zoster.

The other categories of people listed in the question, such as all staff in contact with the patient, all family members, and all children, may also benefit from receiving immunoglobulin if they are not immune to the virus. However, pregnant women who are not immune are at a higher risk for complications and should be prioritized for immunoglobulin administration.

It is important to seek medical care immediately if varicella zoster develops, as prompt treatment can help reduce the severity of symptoms and prevent complications.

Pregnant women who are newly diagnosed with HIV and initiated on antiretroviral therapy (ART) for the first time need to have their viral load (VL) monitored closely to ensure that the treatment is effective in suppressing the virus. The first VL test is typically conducted at 3 months on ART to assess the response to treatment and to determine if viral suppression has been achieved.

Monitoring the VL at 3 months allows healthcare providers to make any necessary adjustments to the treatment regimen if the viral load is not adequately suppressed. This early assessment is crucial for pregnant women to ensure that the virus is controlled during pregnancy, reducing the risk of mother-to-child transmission of HIV.

By conducting the first VL test at 3 months on ART, healthcare providers can intervene promptly if needed and provide the necessary support to ensure a healthy pregnancy outcome for both the mother and the baby. Regular monitoring of the VL throughout pregnancy is essential to maintain viral suppression and reduce the risk of transmission to the baby.

When managing drug interactions between DTG (dolutegravir) and rifampicin, it is important to consider that rifampicin can reduce the concentrations of DTG in the body. This can potentially lead to decreased effectiveness of DTG in treating HIV infection.

The recommended approach for managing this interaction is to seek expert advice and adjust the DTG dose accordingly. This may involve increasing the dose of DTG to compensate for the reduced concentrations caused by rifampicin. It is crucial to consult with a healthcare professional or pharmacist who is knowledgeable about HIV treatment to ensure that the DTG dose is adjusted appropriately to maintain therapeutic levels.

Discontinuing rifampicin is not typically recommended, as it is often a necessary medication for treating other conditions such as tuberculosis. Administering DTG and rifampicin together may not be sufficient to overcome the interaction, and replacing DTG with efavirenz is not necessarily the best solution as efavirenz may have its own set of interactions and side effects.

In conclusion, seeking expert advice and adjusting the DTG dose accordingly is the most appropriate approach for managing drug interactions between DTG and rifampicin to ensure optimal treatment outcomes for individuals with HIV infection.

The correct pairing is Herpes simplex type I and herpes encephalitis.

Herpes simplex virus type I is known to cause herpes encephalitis, which is a rare but serious infection of the brain. This condition can lead to inflammation of the brain, seizures, and even death if not treated promptly.

The other pairings are incorrect because they do not match the specific viruses with the corresponding diseases. For example, Human herpesvirus type 7 is not associated with Kaposi’s Sarcoma, and Human herpesvirus type 8 is not associated with Roseola infantum. It is important to correctly match the virus with the disease in order to understand the causes and treatments for each condition.

Orchitis typically affects post-pubertal males and usually occurs 5-7 days after infection. It is important to note that the relief of pain when the testis is elevated, known as a positive Prehn’s sign, is not present in cases of testicular torsion.

Epididymo-orchitis is a condition where the epididymis and/or testes become infected, leading to pain and swelling. It is commonly caused by infections spreading from the genital tract or bladder, with Chlamydia trachomatis and Neisseria gonorrhoeae being the usual culprits in sexually active younger adults, while E. coli is more commonly seen in older adults with a low-risk sexual history. Symptoms include unilateral testicular pain and swelling, with urethral discharge sometimes present. Testicular torsion, which can cause ischaemia of the testicle, is an important differential diagnosis and needs to be excluded urgently, especially in younger patients with severe pain and an acute onset.

Investigations are guided by the patient’s age, with sexually transmitted infections being assessed in younger adults and a mid-stream urine (MSU) being sent for microscopy and culture in older adults with a low-risk sexual history. Management guidelines from the British Association for Sexual Health and HIV (BASHH) recommend ceftriaxone 500 mg intramuscularly as a single dose, plus doxycycline 100 mg orally twice daily for 10-14 days if the organism causing the infection is unknown. Further investigations are recommended after treatment to rule out any underlying structural abnormalities.

All infants with HIV who are taking Pneumocystis pneumonia prophylaxis should continue the prophylaxis until age 1 year and then undergo reassessment for the need for prophylaxis. For children with HIV who are older than 1 year of age, discontinuing Pneumocystis pneumonia prophylaxis should be considered if the child meets the following two criteria:

They have received combination antiretroviral therapy for at least 6 months
They have surpassed the original age-specific CD4 count and percentage threshold for initiating prophylaxis and maintained above that threshold for at least 3 consecutive months.
For children who do not have virologic suppression, the CD4 count and percentage should be reassessed every 3 months, and prophylaxis should be restarted if the age-specific threshold for prophylaxis is once again met.

Steps to manage a patient in primary care:

• Confirm the Diagnosis:
  • HIV Testing: Ensure that the HIV diagnosis is confirmed through appropriate testing, typically with two different types of HIV tests to avoid false positives.
• Baseline Assessment:
  • Medical History and Physical Examination: Obtain a detailed medical history, including any symptoms, previous illnesses, and risk factors. Conduct a thorough physical examination.
  • Baseline Laboratory Tests: These should include:
    • CD4 Count: To assess the patient’s immune status.
    • Viral Load: To determine the level of HIV in the blood.
    • Complete Blood Count (CBC): To check for anemia, leukopenia, or thrombocytopenia.
    • Liver and Kidney Function Tests: To evaluate the patient’s overall health and potential contraindications for certain medications.
    • Screening for Opportunistic Infections: Tests for tuberculosis, hepatitis B and C, and sexually transmitted infections (STIs).
• Counseling and Education:
  • HIV Education: Provide the patient with information about HIV, its transmission, and the importance of adherence to antiretroviral therapy (ART).
  • Treatment Expectations: Discuss the benefits and potential side effects of ART.
  • Adherence Counseling: Emphasize the importance of taking ART consistently and the impact of adherence on treatment success.
  • Disclosure and Support: Offer counseling on the importance of disclosing their HIV status to sexual partners and provide support options.

Once these steps have been taken, one can start initiating treatment.

• Initiate Antiretroviral Therapy (ART):
  • Selection of ART Regimen: Follow the national guidelines (NDOH 2020 guidelines for treatment initiation), typically involving a combination of three antiretroviral drugs.
  • First-Line Regimen: Common first-line regimens in South Africa may include a combination of Tenofovir (TDF), Lamivudine (3TC), and Dolutegravir (DTG).

The HIV virus is a unique retrovirus that has a spherical structure with a diameter of about 120 nm. It contains two copies of positive single-stranded RNA that code for the virus’s nine genes. These RNA copies are enclosed by a conical capsid made up of 2,000 copies of the viral protein p24. The RNA is tightly bound to nucleocapsid proteins and enzymes necessary for the virus’s development, such as reverse transcriptase, proteases, ribonuclease, and integrase. Surrounding the capsid is a matrix composed of the viral protein p17, which helps maintain the integrity of the virion particle.

Reverse transcriptase is an enzyme within the HIV virus that plays a crucial role in the virus’s replication process. It copies the viral single-stranded RNA genome into a double-stranded viral DNA, which can then be integrated into the host cell’s DNA. This integration allows the virus to replicate and produce more viral particles, ultimately leading to the spread of the infection.

Overall, the unique structure and components of the HIV virus, including proteins like p24, p17, and enzymes like reverse transcriptase, play essential roles in the virus’s ability to infect host cells and replicate within the body.

HIV, or human immunodeficiency virus, primarily targets and damages the immune system by attacking CD4 cells, which are crucial for fighting off infections. However, HIV can also directly damage other organ systems in the body.

The brain can be affected by HIV through various neurological complications, such as HIV-associated neurocognitive disorders (HAND) which can lead to cognitive impairment and dementia. The kidneys can also be damaged by HIV, leading to conditions like HIV-associated nephropathy (HIVAN) which can result in kidney failure.

Additionally, HIV can directly damage the heart, leading to cardiomyopathy which is a condition where the heart muscle becomes weakened and cannot pump blood effectively. Lastly, HIV can also affect the gonads, leading to issues with fertility and hormone production.

Therefore, the correct answer is: Brain, kidneys, heart, and gonads.

HIV-positive patients are at an increased risk for opportunistic infections (OIs) due to their compromised immune system. When a low hemoglobin level is present in these patients, it may indicate an underlying OI that is causing anemia. Anemia can be a common complication of OIs such as mycobacterium avium complex (MAC), cytomegalovirus (CMV), or disseminated histoplasmosis.

Prompt diagnosis and treatment of the underlying OI is crucial in these cases to prevent further complications and improve the patient’s overall health.

In contrast, conditions such as hyperlipidemia, immune reconstitution inflammatory syndrome (IRIS), osteoporosis, and lipomastia may also be present in HIV-positive patients, but they do not typically present with a low hemoglobin level as a primary symptom. Therefore, when a low hemoglobin level is identified in an HIV-positive patient, the focus should be on ruling out and treating any underlying opportunistic infections.